Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-013516
Filing Date
2025-02-04
Accepted
2025-02-04 16:27:25
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3925
  Complete submission text file 0000950170-25-013516.txt   5462
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address
CARR EDWARD (Reporting) CIK: 0001273351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 25588668

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)